PERFECT TIME TO BUY. $PFE to $32 before Next Earning
The falling wedge is a bullish price formation that tells a tale of the stock where bulls are gearing up for a new rally.
+
PFE is trading below my estimate of fair value ($68.47). OVERSOLD!
+ Their Earning is expected to return to the $9-10 billion range (Pre-Covid). The current earning is 2.13 billion.
+ Paxlovid, Prevnar, Elliquis, Ibrance, Xeljanz, Enbrel and Zithromax/Zmax continue to be the most effecitive medications.
+ Pfizer, a company that pays dividends, currently has a yield of 6.21%. I have faith in my chart analysis, however, even if there are inconsistencies, dividends will continue to be distributed, which solidifies its attractiveness as a long-term investment opportunity.
Risk-Free & East Gain
+
PFE is trading below my estimate of fair value ($68.47). OVERSOLD!+ Their Earning is expected to return to the $9-10 billion range (Pre-Covid). The current earning is 2.13 billion.
+ Paxlovid, Prevnar, Elliquis, Ibrance, Xeljanz, Enbrel and Zithromax/Zmax continue to be the most effecitive medications.
+ Pfizer, a company that pays dividends, currently has a yield of 6.21%. I have faith in my chart analysis, however, even if there are inconsistencies, dividends will continue to be distributed, which solidifies its attractiveness as a long-term investment opportunity.
Risk-Free & East Gain
Note
Back to TrendlineNote
Going up nowNote
Retesting the Orange line :)Healthy way to go up
Trade closed: target reached
EASY
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.